Novartis AG NVS
150.47 USD -0.75 (-0.50%)
Regular-session close
150.00 -0.47 -0.31%
After hours · Nov 20, 7:17 PM ET
150.24 Day range 152.70
124.36 52-week range 168.62
- YTD
- +9.14%
- 1 year
- +21.00%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 56.67B | 51.72B | 46.66B | 43.46B | 43.97B | |
| 56.67B | 51.72B | 46.66B | 43.46B | 43.97B | |
| 13.70B | 12.83B | 12.47B | 11.58B | 11.73B | |
| 42.98B | 38.90B | 34.19B | 31.88B | 32.24B | |
| 25.33B | 24.35B | 24.42B | 23.93B | 22.18B | |
| 11.20B | 10.02B | 11.37B | 9.17B | 8.64B | |
| 13.25B | 12.57B | 12.52B | 12.19B | 12.83B | |
| 17.64B | 14.54B | 9.77B | 7.95B | 10.06B | |
| 1.14B | 1.01B | 855.00M | 800.00M | 787.00M | |
| 2.38B | 1.70B | 551.00M | 1.13B | 1.63B | |
| 13.98B | 11.94B | 14.85B | 6.96B | 24.02B | |
| 13.98B | 11.94B | 14.85B | 6.96B | 24.02B | |
| 13.98B | 11.94B | 14.85B | 6.96B | 24.02B | |
| 13.97B | 11.94B | 14.85B | 6.96B | 24.02B | |
| 17.00M | 2.00M | -4.00M | 0 | -3.00M | |
| 7.21 | 5.92 | 7.15 | 3.19 | 10.71 | |
| 7.21 | 5.92 | 7.15 | 3.19 | 10.71 | |
| 7.15 | 5.87 | 7.10 | 3.17 | 10.63 | |
| 3.87 | 3.78 | 3.47 | 3.36 | 3.38 | |
| 17.51B | 14.65B | 16.26B | 8.88B | 26.43B | |
| 17.51B | 14.65B | 16.26B | 8.88B | 26.43B | |
| 1.91B | 2.02B | 2.08B | 2.13B | 2.24B |
